Necitumumab (anti-EGFR), 1mg*5

Necitumumab (anti-EGFR), 1mg*5

Evinacumab(anti-ANGPTL3), 1mg

Evinacumab(anti-ANGPTL3), 1mg

Necitumumab (anti-EGFR), 1mg*25

19.336,31 RON
SKU
SKM_A2048_1mg*25

Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.